St Jude Cash End of Year Trend

STJ -- USA Stock  

null 80.82  0.13  0.16%

This module enables investors to look at St Jude various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 1 B, Cost of Revenue of 2.1 B or Earning Before Interest and Taxes EBIT of 1.2 B, but also many exotic indicators such as Interest Coverage of 12.1176, Long Term Debt to Equity of 1.522 or Calculated Tax Rate of 7.86. This module is a perfect complement to use when analyzing St Jude Valuation or Volatility. It can also complement various St Jude Technical models. Also please take a look at analysis of St Jude Correlation with competitors.
Showing smoothed Cash End of Year of St Jude Medical with missing and latest data points interpolated.
Cash End of Year10 Years Trend
Slightly volatile
 Cash End of Year 

Regression Statistics

Arithmetic Mean  737,211,991
Geometric Mean  584,687,347
Coefficient Of Variation  61.84
Mean Deviation  360,223,527
Median  667,000,000
Standard Deviation  455,905,534
Range  1,305,557,000
R Value  0.48
R Squared  0.23
Significance  0.09
Slope  56,650,683

St Jude Cash End of Year Over Time

2016-12-31  667,000,000 
2017-12-31  667,000,000 
2018-12-31  784,705,882 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

St Jude Upcoming Company Events
Upcoming Quarterly ReportJanuary 25, 2017
Next Earnings ReportApril 19, 2017
Also please take a look at analysis of St Jude Correlation with competitors. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.